Dissemination of high-risk clones of extensively drug-resistant pseudomonas aeruginosa in Colombia

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 4, 2015, Pages 2421-2425

  Correa, Adriana ^a   Del Campo, Rosa ^b   Perenguez, Marcela ^a   Blanco, Victor M ^a   Rodríguez Baños, Mercedes ^b   Perez, Federico ^c,d   Maya, Juan J ^a   Rojas, Laura ^a   Cantón, Rafael ^b   Arias, Cesar A ^e,f   Villegas, Maria V ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; CARBAPENEMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CLONE; COLOMBIA; GENE LOCUS; GENETIC VARIABILITY; HYBRIDIZATION; INFECTION PREVENTION; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; TRANSPOSON; CELL CLONE; CROSS INFECTION; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMONAS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CLONE CELLS; COLOMBIA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84949116043     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03926-14     Document Type: Article

References (30)

1. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x.
2. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B. 2014. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20:1-55. http://dx.doi.org/10.1111/1469-0691.12427.
3. Dantas RC, Ferreira ML, Gontijo-Filho PP, Ribas RM. 2014. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. J Med Microbiol 63(Pt 12):1679-1687. http://dx.doi.org/10.1099/jmm.0.073262-0.
4. García-Castillo M, del Campo R, Morosini MI, Riera E, Cabot G, Willems R, van Mansfeld R, Oliver A, Cantón R. 2011. Wide dispersion of ST175 clone despite high genetic diversity of carbapenemnonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol 49:2905-2910. http://dx.doi.org/10.1128/JCM.00753-11.
5. Wright LL, Turton JF, Livermore DM, Hopkins KL, Woodford N. 2014. Dominance of international "high-risk clones" among metallo- - lactamase-producing Pseudomonas aeruginosa in the UK. J Antimicrob Chemother 70:103-110. http://dx.doi.org/10.1093/jac/dku339.
6. Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN. 2014. Epidemiology and carbapenem resistance mechanisms of carbapenemnon- susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J Antimicrob Chemother 69: 1804-1814. http://dx.doi.org/10.1093/jac/dku048.
7. Libisch B, Poirel L, Lepsanovic Z, Mirovic V, Balogh B, Pászti J, Hunyadi Z, Dobák A, Füzi M, Nordmann P. 2008. Identification of PER-1 extended-spectrum -lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol Med Microbiol 54:330-338. http://dx.doi.org/10.1111/j.1574-695X.2008.00483.x.
8. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, Colombian Nosocomial Resistance Study Group. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem- hydrolyzing -lactamase. Antimicrob Agents Chemother 51:1553-1555. http://dx.doi.org/10.1128/AAC.01405-06.
9. Villegas MV, Lolans K, del Rosario Olivera M, Suarez CJ, Correa A, Queenan AM, Quinn JP, Colombian Nosocomial Resistance Study Group. 2006. First detection of metallo- -lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia. Antimicrob Agents Chemother 50:226-229. http://dx.doi.org/10.1128/AAC.50.1.226-229.2006.
10. Correa A, Montealegre MC, Mojica MF, Maya JJ, Rojas LJ, De La Cadena EP, Ruiz SJ, Recalde M, Rosso F, Quinn JP, Villegas MV. 2012. First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases. Antimicrob Agents Chemother 56:5422-5423. http://dx.doi.org/10.1128/AAC.00695-12.
11. Cuzon G, Naas T, Villegas M-V, Correa A, Quinn JP, Nordmann P. 2011. Wide dissemination of Pseudomonas aeruginosa producing -lactamase blaKPC-2 gene in Colombia. Antimicrob Agents Chemother 55: 5350-5353. http://dx.doi.org/10.1128/AAC.00297-11.
12. Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum -lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44:622-632. http://dx.doi.org/10.1128/AAC.44.3.622-632.2000.
13. Dortet L, Poirel L, Nordmann P. 2014. Rapid detection of extendedspectrum- -lactamase-producing Enterobacteriaceae from urine samples by use of the ESBL NDP test. J Clin Microbiol 52:3701-3706. http://dx.doi.org/10.1128/JCM.01578-14.
14. Fournier D, Garnier P, Jeannot K, Mille A, Gomez A-S, Plésiat P. 2013. A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa. J Clin Microbiol 51:3846-3848. http://dx.doi.org/10.1128/JCM.01299-13.
15. Gautom RK. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other Gram-negative organisms in 1 day. J Clin Microbiol 35:2977-2980.
16. Barton BM, Harding GP, Zuccarelli AJ. 1995. A general method for detecting and sizing large plasmids. Anal Biochem 226:235-240. http://dx.doi.org/10.1006/abio.1995.1220.
17. Liu SL, Hessel A, Sanderson KE. 1993. Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc Natl Acad Sci U S A 90:6874-6878. http://dx.doi.org/10.1073/pnas.90.14.6874.
18. Naas T, Cuzon G, Villegas M-V, Lartigue M-F, Quinn JP, Nordmann P. 2008. Genetic structures at the origin of acquisition of the -lactamase bla KPC gene. Antimicrob Agents Chemother 52:1257-1263. http://dx.doi.org/10.1128/AAC.01451-07.
19. Rawat V, Singhai M, Verma PK. 2013. Detection of different -lactamases and their co-existence by using various discs combination methods in clinical isolates of Enterobacteriaceae and Pseudomonas spp. J Lab Physicians 5:21-25. http://dx.doi.org/10.4103/0974-2727.115918.
20. Poirel L, Lambert T, Türkoglü S, Ronco E, Gaillard J, Nordmann P. 2001. Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing -lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother 45:546-552. http://dx.doi.org/10.1128/AAC.45.2.546-552.2001.
21. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, Gales AC, Venezia SN, Quinn JP, Nordmann P. 2010. Worldwide diversity of Klebsiella pneumoniae that produce -lactamase blaKPC-2 gene. Emerg Infect Dis 16:1349-1356. http://dx.doi.org/10.3201/eid1609.091389.
22. Lopez JA, Correa A, Navon-Venezia S, Correa AL, Torres JA, Briceño DF, Montealegre MC, Quinn JP, Carmeli Y, Villegas MV. 2011. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect 17:52-56. http://dx.doi.org/10.1111/j.1469-0691.2010.03209.x.
23. Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP, Colombian Nosocomial Resistance Study Group. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50:2880-2882. http://dx.doi.org/10.1128/AAC.00186-06.
24. Larché J, Pouillot F, Essoh C, Libisch B, Straut M, Lee JC, Soler C, Lamarca R, Gleize E, Gabard J, Vergnaud G, Pourcel C. 2012. Rapid identification of international multidrug-resistant Pseudomonas aeruginosa clones by multiple-locus variable number of tandem repeats analysis and investigation of their susceptibility to lytic bacteriophages. Antimicrob Agents Chemother 56:6175-6180. http://dx.doi.org/10.1128/AAC.01233-12.
25. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gramnegative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35:736-755. http://dx.doi.org/10.1111/j.1574-6976.2011.00268.x.
26. Elias J, Schoen C, Heinze G, Valenza G, Gerharz E, Gerharz H, Vogel U. 2010. Nosocomial outbreak of VIM-2 metallo- -lactamase-producing Pseudomonas aeruginosa associated with retrograde urography. Clin Microbiol Infect 16:1494-1500. http://dx.doi.org/10.1111/j.1469-0691.2009.03146.x.
27. Lee J-Y, Peck KR, Ko KS. 2013. Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: Antimicrobial resistance, virulence and biofilmforming activity. J Med Microbiol 62:1015-1024. http://dx.doi.org/10.1099/jmm.0.055426-0.
28. Maatallah M, Cheriaa J, Backhrouf A, Iversen A, Grundmann H, Do T, Lanotte P, Mastouri M, Elghmati MS, Rojo F, Mejdi S, Giske CG. 2011. Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6:e25617. http://dx.doi.org/10.1371/journal.pone.0025617.
29. Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG. 2010. Molecular epidemiology of metallo- -lactamaseproducing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 54:346-352. http://dx.doi.org/10.1128/AAC.00824-09.
30. Viedma E, Juan C, Acosta J, Zamorano L, Otero JR, Sanz F, Chaves F, Oliver A. 2009. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extendedspectrum -lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother 53:4930-4933. http://dx.doi.org/10.1128/AAC.00900-09.